Skip to main content
  • COVID-19
    • COVID-19 vaccines and cancer
      • FAQs
      • FAQs in-language
      • SerOzNET Study
    • COVID-19 information for people affected by cancer
      • Managing your cancer care in the context of COVID-19
      • Looking after your mental wellbeing
      • Canada
      • Ireland
      • UK
      • USA
    • COVID-19 information for children and young people with cancer
    • Cancer Won’t Wait
    • Cancer and COVID-19 - what it means for our Mob
      • COVID-19 vaccines: Information for Aboriginal and Torres Strait Islander people affected by cancer
      • Act early for our Mob's health
    • Guidance for health professionals
      • Diagnosis
      • Treatment
      • Surgery
      • Medical oncology
      • Radiation oncology
      • Primary care
      • Telehealth
      • Clinical trials
      • Follow-up care
      • Supportive and Palliative care
      • Cancer care for cancer patients with COVID-19
      • COVID-19 vaccines and cancer
      • Recovery
    • Research articles
      • Review articles
      • Data articles
      • Recommendations articles
      • Shared experience articles
      • COVID-19 vaccines and cancer articles
    • Cancer care in the time of COVID-19: A conceptual framework
    • Optimal cancer care during the COVID-19 pandemic: the Principles
    • The impact of COVID-19 on cancer services
    • COVID-19 Recovery: Implications for cancer care
      • Expanded use of telehealth
      • Changes to prevention and early detection
      • Virtual multidisciplinary team meetings
      • Modifications to treatment schedules
      • Hypofractionated radiotherapy
      • Oncology hospital in the home
      • Responsive patient support
      • Innovative care and hospital infrastructure models
      • Shared follow-up and survivorship care
      • Supportive and palliative care
      • Cancer research and clinical trials
      • Collaboration in the oncology sector and data sharing
      • Acknowledgements
  • About us
    • Organisational structure
    • Accountability and reporting
      • Annual reports
    • Who we work with
      • Roles & functions
      • Advisory Council
      • Advisory groups
      • Consumer engagement
      • Government cancer control organisations
    • Information publication scheme
      • Information publication scheme plan
      • Freedom of information act
        • The FOI request process
      • FOI disclosure log
    • Reconciliation action plan
    • Employment opportunities
  • News and media
    • News
    • Subscribe to our eNewsletter
  • Contact us
Cancer Australia
Choose Language
  • العربية
  • 简体中文
  • 繁體中文
  • Ελληνικά
  • हिन्दी
  • Italiano
  • 한국어
  • Español
  • Tagalog
  • Tiếng Việt
  • العربية
  • 简体中文
  • 繁體中文
  • Ελληνικά
  • हिन्दी
  • Italiano
  • 한국어
  • Español
  • Tagalog
  • Tiếng Việt
  • العربية
  • 简体中文
  • 繁體中文
  • Ελληνικά
  • हिन्दी
  • Italiano
  • 한국어
  • Español
  • Tagalog
  • Tiếng Việt
  • Home
  • Cancer types
  • Impacted by Cancer
  • Awareness
  • Research
  • Resources
  • Clinicians hub
  • Key initiatives
  • Home
  • Cancer types
    • Bladder cancer
    • Bowel cancer
    • Brain cancer
    • Breast cancer
    • Breast cancer in men
    • Breast cancer in young women
    • Cervical cancer
    • Children’s cancer
    • Endometrial cancer
    • Fallopian cancer
    • Gestational trophoblastic disease
    • Gynaecological cancers
    • Head and neck cancer
    • Kidney cancer
    • Leukaemia
    • Liver cancer
    • Lung cancer
    • Lymphoma
    • Melanoma
    • Mesothelioma cancer
    • Myeloma
    • Neuroendocrine tumours
    • Oesophageal cancer
    • Ovarian cancer
    • Pancreatic cancer
    • Prostate cancer
    • Sarcoma
    • Stomach cancer
    • Testicular cancer
    • Thyroid cancer
    • Unknown primary cancer
    • Uterine sarcoma
    • Vaginal cancer
    • Vulvar cancer
  • Impacted by Cancer
    • What is cancer
    • Physical changes
    • Treatment
    • Keeping healthy
    • Emotions
    • Family and relationships
    • Living with cancer
    • Lynch Syndrome
  • Awareness
    • Your cancer risk
    • Screening
    • Interactive body map
  • Research
    • Cancer Research in Australia
    • Data and statistics
    • Australian Clinical Trials
    • Support for cancer clinical trials
    • Grants and funding
  • Resources
    • Cancer Australia Publications
    • Clinical Practice Guidelines
    • Position statements
    • Resources in other languages
    • Cancer Australia websites
    • Cancer risk online assessment tools
    • Other tools and resources
    • Podcasts
    • Cancer support organisations
    • Glossary
  • Clinicians hub
    • GP guides and resources
    • Guidelines by cancer type
    • Optimal Care pathways
    • Working with Aboriginal and Torres Strait Islander people
    • Multidisciplinary care
    • Psychosocial care
    • Follow-up care
    • Family cancer clinics
    • Cancer Learning
    • Consumer engagement
  • Key initiatives
    • For Aboriginal and Torres Strait Islander people
    • Australian Cancer Plan
    • Australian Brain Cancer Mission
    • Lung Cancer Screening
    • National Pancreatic Cancer Roadmap
    • Campaigns & events
    • Jeannie Ferris Recognition Award

Vaginal cancer

vaginal-mm cancer-types/vaginal-cancer/overview
    • Home
    • Types
    • Statistics
    • Risk factors
    • Symptoms
    • Diagnosis
      • Staging and grading
      • VAIN
    • Treatment
      • Effects on fertility
    • Living with
      • Physical changes
      • Emotional changes
    • Life after
    • Finding support
    • Clinical trials
    • Health professionals
    • Home
    • Types
    • Statistics
    • Risk factors
    • Symptoms
    • Diagnosis
      • Staging and grading
      • VAIN
    • Treatment
      • Effects on fertility
    • Living with
      • Physical changes
      • Emotional changes
    • Life after
    • Finding support
    • Clinical trials
    • Health professionals
  1. Home
  2. Diagnosis
  • Staging and grading
  • VAIN
Loading...

How is vaginal cancer diagnosed?

  • Printer-friendly version
  • A|A

You might have some or all the following tests to confirm a diagnosis of vaginal cancer.

Once vaginal cancer is suspected, you should be referred to a gynaecologic oncologist. This is a doctor who has specialist training in cancer of the female reproductive system.

Physical examination and medical history

At the hospital, the gynaecologic oncologist will do a full pelvic examination. This will include examining the inside of your vagina to check for any lumps or swellings. The doctor will also feel your groin and pelvic area to check for any swollen glands, and may also check your rectum.

You will also have a test to check for cell changes in the vagina or cervix. Your doctor or nurse will use an instrument called a speculum to open the vagina and see your cervix. Your doctor or nurse will then collect some cells from the cervix using a small brush or spatula. This may feel slightly uncomfortable, but does not take very long. The cells are then sent to a laboratory where they are examined under a microscope for abnormalities. The results are usually available within 2 weeks.

The doctor will also ask you about your medical history.

[accordion collapsed]

Colposcopy

If the cells taken in the smear test are abnormal, your doctor may ask you to have a colposcopy.

This is a closer examination of the vagina using a colposcope, which is a small low-powered microscope that allows the doctor or specialist nurse to see the vagina in more detail.

A colposcope looks like a pair of binoculars sitting on a large stand. It does not enter the body – the doctor inserts an instrument called a speculum into your vagina and then views a magnified picture of the vagina, cervix and vulva through the colposcope.

Some colposcopes are fitted with a camera that is connected to a TV screen. This may allow you to watch what the doctor is doing. You should feel free to ask the doctor or nurse to explain what is happening.

[accordion collapsed]

Biopsy

A small sample of tissue will be taken from any abnormal areas and sent to a pathologist to be examined under a microscope.

Further tests

If the above tests show that you have vaginal cancer, further tests may be necessary to find out whether any cancer cells have spread (metastasised) to other parts of the body (see Staging and grading). The results will help you and your doctor decide on the best treatment for you.

You may have 1 or more of the following tests.

Chest X-ray and blood tests

These are necessary to assess your general health and to check if the cancer has spread to the lungs.

CT, MRI or PET scans

Computerised tomography (CT) or magnetic resonance imaging (MRI) scans allow doctors to see pictures of the organs and other structures (including tumours) in your body. They are usually done at a hospital or radiology clinic.

Your doctor may also ask for a positron emission tomography (PET) scan (a type of nuclear imaging test). 

Lymphangiogram

Lymphangiogram is a procedure used to X-ray the lymph system. A dye is injected into the lymph vessels in the feet. The dye travels upwards through the lymph nodes and lymph vessels, and X-rays are taken to see if there are any blockages. This test helps find out whether cancer has spread to the lymph nodes.

Endoscopy

Endoscopy refers to any procedure where the doctor inserts a thin tube in the body to look inside. There are different types of endoscopies, depending on the area of the body your doctor wants to examine. These tests are usually only done if the doctor thinks the cancer may have spread to different areas.

Cystoscopy

Cystoscopy is a test that allows the doctor to look at the interior lining of the bladder and the urethra, to see if the cancer has spread to this region. The cystoscope is a slender tube with a lens and a light that is inserted into the urethra and moved into the bladder.

Ureteroscopy

Ureteroscopy is a procedure to look inside the ureters to check for abnormal areas. Ureters are long, thin tubes that carry urine from the kidneys to the bladder.

A ureteroscope is inserted through the bladder and into the ureters, to see if cancer has spread to this region. A ureteroscope is a thin, tube-like instrument with a light and a lens for viewing. It may also have a tool to remove tissue to be checked under a microscope for signs of disease.

Ureteroscopy and cystoscopy may be done during the same procedure.

Proctosigmoidoscopy

Proctosigmoidoscopy is a procedure to look inside the rectum and part of the colon to check for abnormal areas. A thin, tube-like instrument with a light and a lens for viewing is inserted into the rectum. The instrument is called a proctoscope or a sigmoidoscope, and may also have a tool to remove tissue to be checked under a microscope for signs of disease.

Staging and grading

The stage of a cancer is a term used to describe its size and whether it has spread beyond its original area of the body.

The grade of a cancer describes how quickly the tumour is likely to grow.

Knowing the grade and stage of the cancer helps doctors decide on the most appropriate treatment.

Staging

If tests find vaginal cancer, 1 of the following stages will be used to describe your cancer:

  • Stage 1: The cancer is only in the vagina and has not spread.
  • Stage 2: The cancer has begun to spread through the wall of the vagina, but has not spread further into the walls of the pelvis.
  • Stage 3: The cancer has spread to the pelvis and may also be in the lymph nodes close to the vagina.
  • Stage 4: The cancer has spread to the bladder or the bowel, or to other parts of the body such as the lungs.

Grading

Grading refers to the appearance of the cancer cells under the microscope and gives an idea of how quickly the cancer may develop.

Low grade means the cancer cells look like normal cells. They are usually slow growing and are less likely to spread.

High grade means the cells look very abnormal. They are likely to grow more quickly and to spread.

Diagnosing vaginal intraepithelial neoplasia (VAIN)

During a physical examination, it is usually hard for the doctor to see any abnormalities on the lining of the vagina. This is made harder by the fact that VAIN is often high up in the vagina and in multiple places (multifocal).

If your doctor thinks you may have VAIN, you will be recommended to have a colposcopy and a biopsy to assess how likely the VAIN will develop into cancer, and if it should be treated.

Pathologists assess the seriousness of VAIN from the biopsy. Among other things, they look at how superficial or deep the abnormal cells have spread, and grade the risk of cancer developing. There are 3 grades of VAIN: VAIN1, VAIN2 and VAIN3. VAIN1 often goes away on its own, but VAIN2 and VAIN3 are often treated before they develop into vaginal cancer.

  • Last Updated
  • Relevant Links
updated: 3 January 2023 - 1:07pm
American Cancer Society, Vaginal cancer
National Cancer Institute (US), Vaginal cancer treatment (PDQ®), patient version
Australian Cancer Trials
Cancer Council, Vaginal cancer
Australian Gynaecological Cancer Foundation
Rare Cancers Australia
American Cancer Society, Vaginal cancer
The Royal Women’s Hospital, Vaginal cancer

Related information

What is cancer?
What is cancer?

Cancer is a disease of the cells, which are the body’s basic building blocks.

Treatment and side effects
Treatment and side effects

The treatment that your doctors recommend will depend on the type of cancer you have, how advanced it is, and other personal factors.

Living with cancer
Living with cancer

A diagnosis of cancer marks the beginning of a journey full of emotional, psychological, physical and practical challenges.

Life after cancer
Life after cancer

While looking forward to finishing their cancer treatment and getting on with life, for some people, the end of treatment can also be a confusing or worrying time.

A-Z List of Cancer Types

Information on more than 70 types of cancer

  • Bladder cancer
  • Bowel cancer
  • Brain cancer
  • Breast cancer
  • Breast cancer in men
  • Breast cancer in young women
  • Cervical cancer
  • Children's Cancer
  • Endometrial cancer
  • Fallopian cancer
  • Gestational trophoblastic disease
  • Gynaecological cancers
  • Head and neck cancer
  • Kidney cancer
  • Leukaemia
  • Liver cancer
  • Lung cancer
  • Lymphoma
  • Melanoma of the skin
  • Mesothelioma cancer
  • Myeloma
  • Neuroendocrine tumours
  • Oesophageal cancer
  • Ovarian cancer
  • Pancreatic cancer
  • Prostate cancer
  • Sarcoma
  • Stomach cancer
  • Testicular cancer
  • Thyroid cancer
  • Unknown primary
  • Uterine sarcoma
  • Vaginal cancer
  • Vulval cancer

About Cancer Australia

Cancer Australia was established by the Australian Government in 2006 to benefit all Australians affected by cancer, and their families and carers. Cancer Australia aims to reduce the impact of cancer, address disparities and improve outcomes for people affected by cancer by leading and coordinating national, evidence-based interventions across the continuum of care.

If you would like an interpreter to help you understand any information on this website, please call TIS National on 131 450 and ask them to call Cancer Australia on 02 9357 9400. Our business hours are 9am to 5pm, Monday to Friday.

Freecall 1800 624 973
+61 2 9357 9400

Locked Bag 3, Strawberry Hills
NSW 2012

Navigation

  • Cancer types
  • Impacted by Cancer
  • Awareness
  • Research
  • Resources
  • Clinicians hub
  • Key initiatives

Contact us

* Denotes mandatory fields
 

By submitting this form, you accept the Cancer Australia privacy policy.

  • Contact Us
  • Copyright
  • Disclaimer
  • Privacy policy
  • Sitemap
Copyright © 2023 - Cancer Australia